Illinois Adds Two New Medical Marijuana Qualifying Conditions
More Than 200,000 People Were Arrested For Marijuana Possession In The U.S. Last Year, FBI Data Shows
DEA Releases Full Marijuana Rescheduling Hearing Transcript As Judge Prepares To Issue His Recommendation
Reports Of Increases In Problematic Cannabis Use Don’t Mean We Should Return To Prohibition (Op-Ed)
Texas Democrats Say GOP Lieutenant Governor Pushed For Hemp THC Product Ban To Benefit His Alcohol Industry Donors
CDC Wants To Add New Question About Marijuana’s Medical Benefits To Federal Health Survey
More Americans Are Now Smoking Marijuana Than Ever Before As Cigarettes Hit All-Time Low, Gallup Poll Shows
Cannabis Drinks Help People Consume Less Alcohol While Improving Sleep And Mood, Study Finds
Oregon’s Psilocybin Program Helps People Improve Mental Health, Federally Funded Study Published By American Medical Association Shows
Medical Marijuana Improves Sleep Satisfaction And Boosts Quality Of Life, Study Shows
SXSW Is Considering Marijuana And Psychedelics Panel Proposals For 2027 Festival, And You Can Vote On Them
Boxing And Combat Sports Officials Consider Marijuana Breathalyzer Device For Fighters
Sports Leagues Should Reduce Anti-Marijuana Stigma And Provide Honest Education For Athletes, New NFL-Funded Study Concludes
State Marijuana Officials Educate World Cup Fans About How To Celebrate Legally And Responsibly While Visiting
WNBA Removes Marijuana From Banned Substances List And Sets Rules For Player Endorsements Of Hemp CBD Products
Workers At Another Missouri Marijuana Business Secure A Union Contract
Marijuana Could Generate $111 Billion In Tax Revenue Over A Decade If Legalized Federally And In All 50 States, Yale Report Shows
Illinois Recreational Marijuana Dispensaries Can Apply To Sell Medical Cannabis With New Form Posted By State Officials
Alcohol Retailers And Wholesalers Support Bill To Keep Hemp THC Drinks Federally Legal
Square Tells Businesses To Stop Selling Hemp And CBD Products In Light Of Upcoming Federal Ban
DEA releases cannabis rescheduling hearing transcript (Newsletter: August 26, 2026)
Cannabis smoking outpaces cigarettes in US, Gallup poll shows (Newsletter: August 25, 2026)
DEA judge orders cannabis rescheduling transcript corrections (Newsletter: August 24, 2026)
FDA wants help monitoring cannabis convos on social media (Newsletter: August 21, 2026)
Lawmakers press Trump for cannabis rescheduling guidance (Newsletter: August 20, 2026)
Published
on
By
The Centers for Disease Control and Prevention (CDC) is proposing to add a new question to an annual health survey that would ask how often people use marijuana and whether they are doing so for specific medical reasons or if it is just “for fun or to get high.”
The agency’s proposed 2028 National Health Interview Survey (NHIS) would include a query that asks, “Do you currently use marijuana every day, most days, some days, or not at all?”
Respondents can choose “every day,” “most days,” “some days” or “not at all,” and the question caveats that people should not include “CBD only products” when thinking about their answer to the question.
People who indicate that they do use marijuana on at least some days would see a follow-up question that asks, “For what reason or reasons do you use marijuana?”
They can select from:
The federal health agency’s interest in people’s medical use of cannabis comes as the Trump administration is moving forward with the process of rescheduling marijuana.
Attorney General Todd Blanche in April issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I of the Controlled Substances Act (CSA) to Schedule III.
Under a separate order the acting attorney general signed, a hearing is considering more comprehensively moving marijuana to Schedule III.
The Drug Enforcement Administration (DEA), which is charged with defending the proposed rescheduling move, said in its final hearing brief filed last week that “marijuana no longer fits the statutory requirements for Schedule I because it has a currently accepted medical use within the United States and it has an accepted safety for its use under medical supervision.”
The agency noted that under the law it must give “significant deference” to an “extensive ten-month study on the scientific and medical properties” of cannabis conducted by the Department of Health and Human Services (HHS), which recommended rescheduling.
“Currently there are over 30,000 practitioners treating more than six million patients in 43 U.S. jurisdictions,” DEA said. “Such practices demonstrate that there is no longer a lack of accepted safety for use of marijuana under medical supervision, and as such, marijuana does not fulfill the requirements of being a Schedule I substance.”
It also said that there is “substantial evidence sufficient to show that marijuana’s abuse and dependency profiles better align with Schedule III substances than Schedule II” or Schedule I. “The vast majority of individuals who use marijuana do so in a manner that does not result in dangers to themselves or to their communities.”
In conclusion, DEA asked the judge overseeing the hearing to “expeditiously recommend” that marijuana be transferred from Schedule I to Schedule III.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Meanwhile, CDC is accepting public comments on the marijuana question and other aspects of its proposed 2028 survey redesign through October 20, CDC said on its website—though a Federal Register notice says that comments “must be received on or before October 19.”
The previous 2024 version and current 2026 edition of CDC’s NHIS include a question that reads, “During the past 30 days, how often did you use marijuana or CBD products to help you fall asleep or stay asleep?”
A CDC report on the 2024 results showed that 3.7 percent of adults used marijuana or CBD products as sleep aids.
The draft 2028 NHIS that is being circulated by CDC does not include the question about CBD and sleep.
Tom Angell is the editor of Marijuana Moment. A 25-year veteran in the cannabis and drug law reform movement, he covers the policy, politics, science and culture of marijuana, psychedelics and other substances. He previously reported for Forbes, Marijuana.com and MassRoots, and was given the Hunter S. Thompson Media Award by NORML and has been named Journalist of the Year by Americans for Safe Access. As an activist, Tom founded the nonprofit Marijuana Majority and handled media relations, campaigns and lobbying for Law Enforcement Against Prohibition and Students for Sensible Drug Policy.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2026 Marijuana Moment LLC ® and Tom Angell